View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Japan |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2026-08-31 |
| Par Value | 100000000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 100000.00 |
| Coupon | 0.32 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 100000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Astellas Pharma Inc. corporate bond has a 0.32% fixed rate coupon paid on a semi-annual basis. It was issued on August 31, 2023 with an issue size of 100000.00 million JPY and matures on August 31, 2026 with a last coupon date of February 28, 2026. |
Astellas Pharma Inc., founded in 2005 and headquartered in Tokyo, Japan, is a leading global pharmaceutical company dedicated to improving the health of patients through innovative medicines. The company specializes in a range of therapeutic areas, including urology, oncology, immunology, and neuroscience, with key products such as Xtandi, a treatment for prostate cancer, and Betanis for overactive bladder.